Side Effects of GLP-1 and GIP Medications GLP-1 Medications Gastrointestinal Issues: Common side effects include nausea, vomiting, and diarrhea
This innovative approach provides synergistic benefits that exceed the sum of individual treatments
Amgen updated data from its Phase I study of the weight loss drug AMG133 at the 2022 American Heart Association Annual Scientific Sessions (AHA)
Some authorities (Elder et al) have stated that these different growth patterns require cellular alteration or transformation to progress to the next, more biologically aggressive phase
Usage Instructions Inject once weekly under the skin (abdomen, thigh, upper arm) Start at 0.25 mg weekly for 4 weeks, then increase as directed Doses may be raised to 0.5 mg, 1 mg, or 2 mg weekly Use at the same time each week (with or without food) Rotate injection sites to prevent skin irritation Side Effects Nausea, vomiting, diarrhea or constipation Loss of appetite Fatigue or headache Rare: pancreatitis, gallbladder problems, kidney injury, allergic reactions Increased risk of thyroid tumors in animal studies (not seen in humans) Side effects are often mild and improve with time
Ah-Kee EY, Li Yim JF
